Leica unveiled the Tissue IA 2.0 digital pathology image analyzer that does fluorescence and brightfield analysis in a single device. It also does high precision cell modeling and features dual staining capability:
A major challenge in research today is retrieval of quantitative, reproducible data from tissuebased IHC studies. Tissue IA 2.0 provides expert tools for researchers to extract the most from their studies. Powerful color separation and multi-marker colocalization functionality provides advanced insight and unbiased measurement of multiple antigen immunostaining in brightfield or fluorescent samples. Sophisticated cell modelling accurately detects and quantifies differential expression of staining in cellular compartments, providing detailed insight into cytoplasmic, membrane and nuclear biomarker localization.
The advanced dual staining capabilities in Tissue IA2.0 enable researchers to identify cell cohorts at the molecular level. Use one marker to identify a population of interest and then quantify expression of a second, providing exceptional analysis performance and greater understanding of your slides. Algorithms are easily adjusted and optimized for different markers, tissue and protocols giving a flexible platform for drug discovery applications.
Easy to deploy and easy to use, the Tissue IA web-accessible interface means that users can take their analysis with them wherever they go. With high throughput batch analysis capacity, Tissue IA 2.0 will process whole slides, regions of interest or tissue microarray cores, and automatically integrate analysis results with your slides. A built-in upload interface facilitating integration of algorithms from 3rd party software solutions, gives greater flexibility to further expand your analysis options.
Product page: Tissue IA…